| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014461 |
| Receipt No. | R000016824 |
| Official scientific title of the study | The study on the usefulness of fucoidan-containing food intake for early or unresectable advanced gastric cancer patients |
| Date of disclosure of the study information | 2014/09/01 |
| Last modified on | 2017/07/04 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | The study on the usefulness of fucoidan-containing food intake for early or unresectable advanced gastric cancer patients | |
| Title of the study (Brief title) | The study on the usefulness of fucoidan intake for gastric cancer patients | |
| Region |
|
|
| Condition | ||
| Condition | early or unresectable advanced gastric cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the effects on immune function and so on by intaking food including fucoidan for early gastric cancer patients or unresectable advanced gastric cancer patients with the standard chemotherapy as first-line treatment. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To assess immune monitoring such as cytokines, QOL evaluation and intestinal flora analysis. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | To intake fucoidan-containing food every day. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Histologically confirmed gastric cancer.
2) Patients informed diagnosis of their disease. 3) Aged from 20 over years. 4) Grade 0 to 2 in performance status (ECOG). 5) In early gastric cancer patients, patients with confirmed the curative resection with endoscopic treatment. 6) In advanced gastric cancer patients, patients who are scheduled to newly primary chemotherapy. 7) Expected to be alive at least six months after informed consent in advanced gastric cancer patients. 8) Having written informed consent. |
|||
| Key exclusion criteria | 1) Presence of severe complications (heart failure, liver desease, renal desease).
2) Presence of infectious disease. 3) Taking the drug affecting immune system such as steroid and immunosuppresant. 4) Taking the supplement affecting immune system. 5) Inappropriate patients for study judged by the physicians. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Yuji Naito |
| Organization | Kyoto Prefectural University of Medicine |
| Division name | Molecular Gastroenterology and Hepatology |
| Address | 465, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan |
| TEL | 075-251-5519 |
| ynaito@koto.kpu-m.ac.jp | |
| Public contact | |
| Name of contact person | Yuji Naito |
| Organization | Kyoto Prefectural University of Medicine |
| Division name | Molecular Gastroenterology and Hepatology |
| Address | 465, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan |
| TEL | 075-251-5519 |
| Homepage URL | |
| ynaito@koto.kpu-m.ac.jp | |
| Sponsor | |
| Institute | Kyoto Prefectural University of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kyoto Prefectural University of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | TAKARA BIO, INC |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 京都府立医科大学附属病院(京都府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016824 |